Adverse Events Associated with Disease-Modifying Drugs for Multiple SclerosisNeurol 102:e208006, Ng, HS.,et al, 2024
Initial Highly Effective Therapy for MSNeurol 95:1114-1116, Wallin, M.T., 2020